• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 186
  • 62
  • 60
  • 26
  • 22
  • 10
  • 10
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • Tagged with
  • 457
  • 179
  • 109
  • 85
  • 78
  • 63
  • 63
  • 62
  • 47
  • 47
  • 44
  • 41
  • 39
  • 37
  • 33
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

The role of transforming growth factor-β in thymocyte development and T cell function

Maurice, Diane Barthelemie Emile January 2002 (has links)
No description available.
2

Alterations in Tgf-β Signaling Mediate the Biologic Behaviour of Osteosarcoma Cell Lines

Deheshi, Benjamin Michael 31 December 2010 (has links)
Osteosarcoma is a mesenchymal tumour of bone common among children and young adults. Prognosis is poor if metastases are present at diagnosis. The transforming growth factor beta (TGF-β) signaling pathway plays a complex dual role in cancer. We hypothesized that alterations in the TGF-β signaling pathway are important in the tumorigenesis of osteosarcoma cell lines. Smad phosphorylation and nuclear localization, Smad4 expression, and TAZ expression were determined in the HOS osteosarcoma cell line and tumorigenic derivatives. Basal TGF-β activity and TAZ expression correlated with a tumorigenic phenotype in the KHOS cell lines as measured by Anchorage Independent Growth (AIG). In comparison, exogenous TGF-β suppressed AIG and acted as a tumour suppressor, while Smad4-deficient KHOS cells were resistant to the inhibitory TGF-β effect. In conclusion, basal TGF-β signaling and TAZ correlate with increased tumorigenic potential in osteosarcoma cell lines, whereas exogenous TGF-β acted as a tumour suppressor in a Smad4-dependent manner.
3

Alterations in Tgf-β Signaling Mediate the Biologic Behaviour of Osteosarcoma Cell Lines

Deheshi, Benjamin Michael 31 December 2010 (has links)
Osteosarcoma is a mesenchymal tumour of bone common among children and young adults. Prognosis is poor if metastases are present at diagnosis. The transforming growth factor beta (TGF-β) signaling pathway plays a complex dual role in cancer. We hypothesized that alterations in the TGF-β signaling pathway are important in the tumorigenesis of osteosarcoma cell lines. Smad phosphorylation and nuclear localization, Smad4 expression, and TAZ expression were determined in the HOS osteosarcoma cell line and tumorigenic derivatives. Basal TGF-β activity and TAZ expression correlated with a tumorigenic phenotype in the KHOS cell lines as measured by Anchorage Independent Growth (AIG). In comparison, exogenous TGF-β suppressed AIG and acted as a tumour suppressor, while Smad4-deficient KHOS cells were resistant to the inhibitory TGF-β effect. In conclusion, basal TGF-β signaling and TAZ correlate with increased tumorigenic potential in osteosarcoma cell lines, whereas exogenous TGF-β acted as a tumour suppressor in a Smad4-dependent manner.
4

Identification of target genes of SMAD4 signaling network inhibit pancreatic tumor metastasis and chemoresistance

Huang, Sz-yang 08 July 2010 (has links)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most insidious forms of cancer whose incidence nearly equals its death rate. Despite extensive research studies, no effective therapeutic approaches for diminishing the morbidity associated with this disease are available. PDAC is characterized by activating Kras mutations and inactivation of Ink4a and the p53-Arf pathway in virtually all cases, while SMAD4¡Xa central regulator of Transforming growth factor-beta (TGF-£]) signaling¡Xis inactivated in 55% of PDAC. Our overall goal is to understand how perturbations in the inactivation of SMAD4 pathway contribute to the late stages of PDAC pathogenesis, and to elucidate the role of SMAD4 inactivation on the conversion of a benign form of the cancer to a more aggressive metastatic form. To address this important topic in cancer biology, we have devised a strategy to develop model cell lines to dissect the role of SMAD4 defect in PDAC cell lines and the potential synergistic effects of hypoxia and/or TGF-£]1 upon SMAD4 inactivation in their metastatic properties. Experiment results showed SMAD4 restored in PDAC model cell lines were down regulate HIF-1£\, VEGF, FGF10 and FGFR2 genes expression level, and also inhibited migration, chemoresistance and angiogenesis of cancer cells. We hypothesize that these effects are due to SMAD4 suppresses some cancer genes in PDAC. Further detailed investigations are also needed to fully elucidate the detail mechanisms for our findings here therefore, the future works of this study will go step on looking for those important downstream effect genes regulated by Smad4 protein in PDAC cells and try to find out the connection of all the dependence proteins.
5

Low dose radiation interations with the transformation growth factor (TGF)-beta pathway

Maslowski, Amy Jesse 15 May 2009 (has links)
A major limiting factor for long-term, deep-space missions is the radiation dose to astronauts. Because the dose to the astronauts is a mixed field of low- and high-LET radiation, there is a need to understand the effects of both radiation types on whole tissue; however, there are limited published data on the effects of high-LET (linearenergy- transfer) radiation on tissue. Thus, we designed a perfusion chamber system for rat trachea in order to mimic in vivo respiratory tissue. We successfully maintained the perfused tracheal tissue ex vivo in a healthy and viable condition for up to three days. In addition, this project studied the effects of high-LET Fe particles on the overall transformation growth factor (TGF)-beta response after TGF-beta inactivation and compared the results to the TGF-beta response post x-ray irradiation. It was found that a TGF-beta response could be measured in the perfused tracheal tissue, for x-ray and Fe particle irradiations, despite the high autofluorescent background intrinsic to tissue. However, after comparing the TGF-beta response of x-ray irradiation to High-Z-Highenergy (HZE) irradiation, there was not a significant difference in radiation types. The TGF-beta response in x-ray and HZE irradiated perfusion chambers was also measured over time post irradiation. It was found that for 6 hour and 8 hour post irradiation, the TGF-beta response was higher for lower doses of radiation than for higher doses. This is in contrast to the 0 hour fixation which found the TGF-beta response to increase with increased dose. The inverse relationship found for 6 hour and 8 hour fixation times may indicate a threshold response for TGF-beta response; i.e., for low doses, a threshold of dose must be reached for an immediate TGF-beta response, otherwise the tissue responds more slowly to the irradiation damage. This result was unexpected and will require further investigation to determine if the threshold can be determined for the 250 kVp x-rays and 1 Gev Fe particles.
6

Estudo da influência do fator de transformação de crescimento - Beta 1 (TGF-b1) em cultura de células osteogênicas induzidas com fatores mineralizantes / Study of the influence of TGF-b1 in osteogenic cell culture induced by mineralizing factors.

Donato, Tatiani Ayako Goto 16 October 2009 (has links)
O estudo investigou a influência do fator de transformação de crescimento beta1 (TGFb1) sobre células osteogênicas induzidas com fatores mineralizantes (dexametasona Dex), comparando a viabilidade e a proliferação celular, a mineralização, e a expressão de proteínas não colágenas da matriz osteopontina (OPN), sialoproteína óssea (BSP) e fibronectina (FN). A morfologia foi examinada por microscopia eletrônica de transmissão (MET). O TGFb1 diminuiu a viabilidade e a proliferação celular, mesmo com Dex. A mineralização da matriz foi positivo apenas no grupo tratado com Dex, e negativo nos grupos tratados TGFb1 e TGFb1+Dex. OPN e BSP não foram imunoreativas apenas para o controle negativo, já a FN foi imunoexpressa em todos os grupos. A mineralização foi confirmada, tanto no controle positivo quanto no tratado com Dex, e alterações morfológicas foram observadas nas células tratadas com TGFb1 e TGFb1+Dex, através da MET. Esse estudo mostrou que TGFb1 inibe a mineralização, alterando a viabilidade e proliferação, bem como a morfologia celular, mesmo quando tratadas com Dex. / The study investigated the influence of transforming growth factor beta1 (TGFb1) on osteogenic cells induced with mineralizing factors (dexamethasone Dex), comparing the viability and proliferation cellular, the formation of mineral nodules in vitro, and the expression of the noncollagenous matrix proteins osteopontin (OPN), bone sialoprotein (BSP), and fibronectin (FN). The morphology was examined by transmission electron microscopy (TEM). The TGFb1 decreased the viability and proliferation cellular, even when combined with Dex. The mineralization of matrix was positive only in the group treated with Dex, and negative in the groups treated with TGFb1 and TGFb1+Dex. OPN and BSP were not immunoreactive only negative, already the FN was immunoreactive in all groups.The mineralizing was confirmed in the positive control and Dex, through TEM. Some morphological changes were seen in cells treated with TGFb1 and TGFb1+Dex. This study showed that TGFb1 inhibits the mineralization, changing the viability, proliferation and cell morphology, even when treated with Dex.
7

Estudo da influência do fator de transformação de crescimento - Beta 1 (TGF-b1) em cultura de células osteogênicas induzidas com fatores mineralizantes / Study of the influence of TGF-b1 in osteogenic cell culture induced by mineralizing factors.

Tatiani Ayako Goto Donato 16 October 2009 (has links)
O estudo investigou a influência do fator de transformação de crescimento beta1 (TGFb1) sobre células osteogênicas induzidas com fatores mineralizantes (dexametasona Dex), comparando a viabilidade e a proliferação celular, a mineralização, e a expressão de proteínas não colágenas da matriz osteopontina (OPN), sialoproteína óssea (BSP) e fibronectina (FN). A morfologia foi examinada por microscopia eletrônica de transmissão (MET). O TGFb1 diminuiu a viabilidade e a proliferação celular, mesmo com Dex. A mineralização da matriz foi positivo apenas no grupo tratado com Dex, e negativo nos grupos tratados TGFb1 e TGFb1+Dex. OPN e BSP não foram imunoreativas apenas para o controle negativo, já a FN foi imunoexpressa em todos os grupos. A mineralização foi confirmada, tanto no controle positivo quanto no tratado com Dex, e alterações morfológicas foram observadas nas células tratadas com TGFb1 e TGFb1+Dex, através da MET. Esse estudo mostrou que TGFb1 inibe a mineralização, alterando a viabilidade e proliferação, bem como a morfologia celular, mesmo quando tratadas com Dex. / The study investigated the influence of transforming growth factor beta1 (TGFb1) on osteogenic cells induced with mineralizing factors (dexamethasone Dex), comparing the viability and proliferation cellular, the formation of mineral nodules in vitro, and the expression of the noncollagenous matrix proteins osteopontin (OPN), bone sialoprotein (BSP), and fibronectin (FN). The morphology was examined by transmission electron microscopy (TEM). The TGFb1 decreased the viability and proliferation cellular, even when combined with Dex. The mineralization of matrix was positive only in the group treated with Dex, and negative in the groups treated with TGFb1 and TGFb1+Dex. OPN and BSP were not immunoreactive only negative, already the FN was immunoreactive in all groups.The mineralizing was confirmed in the positive control and Dex, through TEM. Some morphological changes were seen in cells treated with TGFb1 and TGFb1+Dex. This study showed that TGFb1 inhibits the mineralization, changing the viability, proliferation and cell morphology, even when treated with Dex.
8

Transforming growth factor-beta signalling in human cutaneous squamous cell carcinoma

Rose, Aidan Michael January 2015 (has links)
There is an urgent need to define the key pathological driving events in human cutaneous squamous cell carcinoma (cSCC) in order to identify novel therapeutic targets. Already the second most common form of human non-melanoma skin cancer, the incidence of cSCC has continued to rise at epidemic proportions over the past two decades. Rarely, cSCC can be highly aggressive, causing significant soft-tissue defects in sun-exposed areas of skin and progressing to metastatic disease, which is usually associated with poor survival. The transforming growth factor-β (TGF-β) signalling pathway is known to play key regulatory roles in skin homeostasis and wound repair. Murine studies indicate that loss of TGF-β signalling is sufficient to drive cSCC, but conclusive evidence for a similar role in human cSCC remains elusive. Combining immunohistochemical and genetic studies of the TGF-β signalling pathway on human cSCC tissue, with a thorough examination of TGF-β responses in human primary cSCC cell lines in-vitro, this thesis aims to investigate the complex role of TGF-β signalling in human cSCC. An extensive tissue micro-array analysis demonstrated the consistent reduction of endogenous TGF-β signalling activity in human primary cSCC. This intriguingly correlated with higher risk thick tumours pathologically, indicating that TGF-β is likely to act primarily as a tumour suppressor in human cSCC and its reduction or loss may impart a significant growth advantage for cSCC tumour cells. This tumour suppressor effect was reflected in-vitro, whereby the majority of primary cSCC cell lines remained sensitive to TGF-β mediated growth arrest. Resistance to TGF-β tumour suppression was also identified, and mechanistically its main protagonist in cSCC cell lines appeared to be mutational loss of TGF-β receptors. Consolidating in-vitro findings, both whole exome sequencing and 454 pyrosequencing of human cSCC tissue revealed frequent functionally damaging mutations of both TGF-β type 1 and type 2 receptors, indicating that mutational loss of the TGF-β pathway may be a key driving event in human cSCC tumourigenesis. Perhaps most interestingly, mutational loss of TGF-β type 2 receptors in cSCC cell lines appeared to result in a novel pro-oncogenic dependence on TGF-β type 1 receptor kinase activity, highlighting not only the important paradoxical role of TGF-β mediated tumour promotion in cSCC, but also the potential for signalling crosstalk between alternative TGF-β superfamily members, namely Activin signalling, to drive tumourigenesis in the absence of active TGF-β signalling. Although further mechanistic studies are required to support this hypothesis, the mutational status of TGF-β type 2 receptors may not only provide a powerful prognostic tool for patients with cSCC, but also represent an important biomarker for the targeted use of TGF-β inhibitors in potentially aggressive disease where pro-tumourigenic responses could be driving disease progression.
9

Control of renal haemodynamics in the developing kidney - implications for fetal programming

Turner, Anita Jillian, Medical Sciences, Faculty of Medicine, UNSW January 2008 (has links)
Renal blood flow and micropuncture studies were conducted in late gestation fetal sheep (gestational age 134 - 141 days; term 150 days) and neonatal lambs (8 - 18 days after birth) to study the forces involved in glomerular filtration (GFR) and characterize the tubuloglomerular feedback (TGF) system during development. These studies required the kidney to be immobilized so stable models in acutely prepared anaesthetized animals were developed. Fetuses were studied in a heated water bath exteriorized from the uterus but with an intact umbilical circulation. The lower GFR in fetuses than lambs was found to be due to both lower net filtration pressures (P<0.001) and a lower ultrafiltration coefficient (P<0.001). TGF was present at both ages, but in fetuses the sensitivity was higher (P<0.001) and reactivity was lower (P<0.001). The reduction in TGF sensitivity between fetal and neonatal life may facilitate the increase in renal blood flow and GFR which occurs at this time. In both fetuses and lambs the sensitivity of the TGF curve was reduced by volume expansion (P<0.001, P<0.05) and reactivity was reduced in lambs (P<0.001). Furosemide abolished TGF at both ages. In both fetuses and lambs, TGF reactivity was increased by inhibition of neuronal nitric oxide synthase (nNOS; P<0.01, P<0.001) and in lambs, TGF sensitivity was increased (P<0.01). This indicates that nitric oxide produced by the macula densa modulates TGF during development. In offspring destined to become hypertensive due to maternal dexamethasone treatment in early gestation TGF sensitivity tended to be enhanced in fetal life and was enhanced in lambs (P<0.01). Increased TGF sensitivity may contribute to the development of hypertension in this model of developmental programming. The effects of nNOS inhibition were attenuated in these animals, suggesting that they have low tonic production of nitric oxide by the macula densa. In fetuses whose mothers had been subtotally nephrectomized prior to mating to induce maternal mild renal impairment, GFR was increased (P<0.01) but net filtration pressure was reduced (P<0.001) so the ultrafiltration coefficient was increased (P<0.001). TGF sensitivity was normal and the effects of nNOS inhibition were similar to normal fetuses.
10

Control of renal haemodynamics in the developing kidney - implications for fetal programming

Turner, Anita Jillian, Medical Sciences, Faculty of Medicine, UNSW January 2008 (has links)
Renal blood flow and micropuncture studies were conducted in late gestation fetal sheep (gestational age 134 - 141 days; term 150 days) and neonatal lambs (8 - 18 days after birth) to study the forces involved in glomerular filtration (GFR) and characterize the tubuloglomerular feedback (TGF) system during development. These studies required the kidney to be immobilized so stable models in acutely prepared anaesthetized animals were developed. Fetuses were studied in a heated water bath exteriorized from the uterus but with an intact umbilical circulation. The lower GFR in fetuses than lambs was found to be due to both lower net filtration pressures (P<0.001) and a lower ultrafiltration coefficient (P<0.001). TGF was present at both ages, but in fetuses the sensitivity was higher (P<0.001) and reactivity was lower (P<0.001). The reduction in TGF sensitivity between fetal and neonatal life may facilitate the increase in renal blood flow and GFR which occurs at this time. In both fetuses and lambs the sensitivity of the TGF curve was reduced by volume expansion (P<0.001, P<0.05) and reactivity was reduced in lambs (P<0.001). Furosemide abolished TGF at both ages. In both fetuses and lambs, TGF reactivity was increased by inhibition of neuronal nitric oxide synthase (nNOS; P<0.01, P<0.001) and in lambs, TGF sensitivity was increased (P<0.01). This indicates that nitric oxide produced by the macula densa modulates TGF during development. In offspring destined to become hypertensive due to maternal dexamethasone treatment in early gestation TGF sensitivity tended to be enhanced in fetal life and was enhanced in lambs (P<0.01). Increased TGF sensitivity may contribute to the development of hypertension in this model of developmental programming. The effects of nNOS inhibition were attenuated in these animals, suggesting that they have low tonic production of nitric oxide by the macula densa. In fetuses whose mothers had been subtotally nephrectomized prior to mating to induce maternal mild renal impairment, GFR was increased (P<0.01) but net filtration pressure was reduced (P<0.001) so the ultrafiltration coefficient was increased (P<0.001). TGF sensitivity was normal and the effects of nNOS inhibition were similar to normal fetuses.

Page generated in 0.0305 seconds